“Metabolic Reprogramming of Leukemia Stem Cells as a Novel Therapeutic Target for Relapsed Acute Myeloid Leukemia”, Pjmcr, vol. 5, no. 1, pp. 5786–5812, Mar. 2026, doi: 10.5281/zenodo.22067075.